NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Stylus Medicine

Stylus Medicine

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.stylusmedicine.com/

Last Round

Series A

Extension

May 13, 2025

Total Funding Raised

$170M

Company Overview

Stylus Medicine is a biotechnology company developing in vivo genetic medicines using engineered recombinase technology and targeted lipid nanoparticle delivery systems.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

in vivo gene therapygenetic medicineCAR-T therapylipid nanoparticlesin vivo editingLNPgene editingnon-viral deliveryengineered recombinasesin vivo CAR-Tgenome integrationbiotech platformnext-gen gene therapyprecision medicinedrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stylus Medicine Comps

Public and private peers based on sector, stage, and business model.

Stylus Medicine comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Stylus Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 13, 2025
Series AMay 12, 2025

Key People

Founding team and executive leadership

Nessan Bermingham

Interim CEO, Board Member, NOne Bio Founder

Founding Team

Stylus Medicine Investors

Notable investors and investment history

Stylus Medicine investors
InvestorRounds
RA Capital ManagementSeries A, Series A Extension
Khosla VenturesSeries A Extension, Series A
Chugai Venture FundSeries A, Series A Extension
Johnson & Johnson Innovation - JJDC, Inc.Series A, Series A Extension
Tachyon VenturesSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 13, 2025

    $45M round led by RA Capital Management.

  • May 12, 2025

    $85M round completed.

Stylus Medicine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Stylus Medicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stylus Medicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range49
Year Founded2022
Last FundingMay 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.